Table of Contents

2019-2024 Global Rifaximin Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Rifaximin Market Size 2014-2024
  • 2.1.2 Rifaximin Market Size CAGR by Region
• 2.2 Rifaximin Segment by Type
  • 2.2.1 200 mg Tablets
  • 2.2.2 550 mg Tablets
• 2.3 Rifaximin Market Size by Type
  • 2.3.1 Global Rifaximin Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Rifaximin Market Size Growth Rate by Type (2014-2019)
• 2.4 Rifaximin Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Drug store
• 2.5 Rifaximin Market Size by Application
  • 2.5.1 Global Rifaximin Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Rifaximin Market Size Growth Rate by Application (2014-2019)

3 Global Rifaximin by Players

• 3.1 Global Rifaximin Market Size Market Share by Players
  • 3.1.1 Global Rifaximin Market Size by Players (2017-2019)
  • 3.1.2 Global Rifaximin Market Size Market Share by Players (2017-2019)
• 3.2 Global Rifaximin Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Rifaximin by Regions

• 4.1 Rifaximin Market Size by Regions
• 4.2 Americas Rifaximin Market Size Growth
• 4.3 APAC Rifaximin Market Size Growth
• 4.4 Europe Rifaximin Market Size Growth
• 4.5 Middle East & Africa Rifaximin Market Size Growth

5 Americas

• 5.1 Americas Rifaximin Market Size by Countries
• 5.2 Americas Rifaximin Market Size by Type
• 5.3 Americas Rifaximin Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Rifaximin Market Size by Countries
• 6.2 APAC Rifaximin Market Size by Type
• 6.3 APAC Rifaximin Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Rifaximin by Countries
• 7.2 Europe Rifaximin Market Size by Type
• 7.3 Europe Rifaximin Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Rifaximin by Countries
• 8.2 Middle East & Africa Rifaximin Market Size by Type
• 8.3 Middle East & Africa Rifaximin Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Rifaximin Market Forecast

• 10.1 Global Rifaximin Market Size Forecast (2019-2024)
• 10.2 Global Rifaximin Forecast by Regions
  • 10.2.1 Global Rifaximin Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Rifaximin Forecast by Type
• 10.8 Global Rifaximin Forecast by Application

11 Key Players Analysis

• 11.1 Salix Pharmaceuticals
  • 11.1.1 Company Details
  • 11.1.2 Rifaximin Product Offered
  • 11.1.3 Salix Pharmaceuticals Rifaximin Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Salix Pharmaceuticals News

...

12 Research Findings and Conclusion

Rifaximin, sold under the trade name Xifaxan among others, is an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It has poor absorption when taken by mouth.

According to this study, over the next five years the Rifaximin market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Rifaximin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Rifaximin market by product type, application, key companies and key regions.

This study considers the Rifaximin value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
200 mg Tablets
550 mg Tablets
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Drug store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Salix Pharmaceuticals
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Rifaximin market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rifaximin market by identifying its various subsegments.
Focuses on the key global Rifaximin players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rifaximin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Rifaximin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.